Life Science & Technology Weekly 121 – Shanghai Pharma buys US Cardinal Health’s China business for $557 billion

Published on: Nov 20, 2017
Author: Editor

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Technology